Active, Not Recruiting
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
NCT05226507
- Conditions
- ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
- Locations
-
- Honor Health Phoenix, Arizona, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale Gynecologic Oncology New Haven, Connecticut, United States